10 Article(s)Download |
PMID | Title | Pub. Year | #Total Relationships |
1 | 33357452 | Immunogenic Chemotherapy Enhances Recruitment of CAR-T Cells to Lung Tumors and Improves Antitumor Efficacy when Combined with Checkpoint Blockade. | 2021 Feb 8 | 1 |
2 | 33417830 | Crosstown Traffic: Lymphodepleting Chemotherapy Drives CAR T Cells. | 2021 Feb 8 | 1 |
3 | 33602823 | Activation of NF-κB and p300/CBP potentiates cancer chemoimmunotherapy through induction of MHC-I antigen presentation. | 2021 Feb 23 | 1 |
4 | 33658858 | The Combination Therapy of Fluorouracil and Oxaliplatin Suppress the Progression of Colon Cancer Through miR-183-5p/SOCS3 Axis and Downregulating PD-L1. | 2021 | 6 |
5 | 34484640 | The Impact of Nrf2 Silencing on Nrf2-PD-L1 Axis to Overcome Oxaliplatin Resistance and Migration in Colon Cancer Cells. | 2021 Jul-Sep | 4 |
6 | 31272718 | PLAC8 overexpression correlates with PD-L1 upregulation and acquired resistance to chemotherapies in gallbladder carcinoma. | 2019 Aug 27 | 1 |
7 | 31290727 | Programmed death-ligand 1 monoclonal antibody-linked immunoliposomes for synergistic efficacy of miR-130a and oxaliplatin in gastric cancers. | 2019 Jul | 1 |
8 | 30042932 | The Interplay of Notch Signaling and STAT3 in TLR-Activated Human Primary Monocytes. | 2018 | 1 |
9 | 25943534 | Identification and Characterization of MEDI4736, an Antagonistic Anti-PD-L1 Monoclonal Antibody. | 2015 Sep | 1 |
10 | 22193989 | The chemotherapeutic drug oxaliplatin differentially affects blood DC function dependent on environmental cues. | 2012 Jul | 2 |